Physician profile
Eric Tannenbaum
NPI 1235404526
$14,339.65
in general payments reported to CMS, 2019-2025
14 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,220 · 2020: $2,556 · 2021: $4,453 · 2022: $1,284 · 2023: $1,188 · 2024: $1,285 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,660 · Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,660.25 |
| Food and Beverage | $1,167.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $4,836.00 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $4,686.32 | 2019-2025 | Avenir, Persona, Comprehensive Shoulder System |
| Stryker Corporation | $3,103.01 | 2020-2025 | Salvation, Accolade, Hipcheck |
| Arthrex, INC. | $894.00 | 2020 | |
| Medical Device Business Services, INC. | $241.35 | 2020 | |
| Depuy Synthes Sales INC. | $198.44 | 2020-2025 | Gryphon Orthocord, Vapr, Fms |
| Mf Med | $158.51 | 2024-2025 | |
| Medacta USA, INC. | $86.69 | 2020 | |
| Endo Pharmaceuticals INC. | $38.33 | 2020-2022 | |
| Avanos Medical | $32.97 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.34 | 2025 | Iovera, Exparel |
| Pacira Therapeutics, INC. | $15.27 | 2020 | |
| Si-Bone, INC. | $13.90 | 2021 | |
| Djo, LLC | $13.52 | 2023 | Donjoy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Tannenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.